Low-Lactose Milk Replacer for Bovine Insulin Resistance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional milk replacers for calves lead to insulin resistance and disrupted glucose homeostasis due to high lactose levels, causing gut health issues and reduced biochemical efficiency, which is detrimental to animal welfare and economics.
Innovation Solution
A low-lactose dairy-based milk replacer with at least 30 wt.% carbohydrates and less than 20 wt.% lactose is administered, where lactose is converted into its monosaccharides glucose and galactose before feeding, preventing insulin resistance and maintaining high carbohydrate levels without causing metabolic issues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional milk replacers with high lactose content are used to provide sufficient carbohydrates, then carbohydrate availability is improved, but insulin resistance and disrupted glucose homeostasis occur
Solution Approach 1:
The patent changes the chemical form of carbohydrates from lactose (disaccharide) to monosaccharides (glucose and galactose) through enzymatic hydrolysis. This parameter change allows the milk replacer to maintain high carbohydrate content while avoiding insulin resistance, as monosaccharides are absorbed directly without causing the metabolic disruption associated with lactose.
Solution Approach 2:
The patent introduces an intermediary substance (lactase enzyme or other hydrolyzing agents) that converts lactose into monosaccharides before the carbohydrates are consumed by the animal. This intermediary mechanism enables the milk replacer to provide sufficient carbohydrates while preventing the harmful metabolic effects of high lactose intake.
2Object-affected harmful factors
If low-lactose milk replacers are used to prevent insulin resistance, then metabolic health is improved, but carbohydrate content decreases requiring additional fat and protein
Solution Approach 1:
The patent changes the state of carbohydrates from intact lactose to hydrolyzed monosaccharides, which allows the milk replacer to maintain high carbohydrate levels (at least 30 wt.%) while having low lactose content. This parameter change eliminates the need to compensate with additional fat and protein, as the monosaccharides provide sufficient energy without causing insulin resistance.
3Productivity
If high protein content (24-28 wt.%) is added to milk replacers to improve growth, then daily weight gain is improved, but gut health issues such as ruminitis and ruminal acidosis increase
Solution Approach 1:
The patent changes the carbohydrate profile from high lactose to high monosaccharide content, which allows the milk replacer to achieve optimal growth without excessive protein levels. The monosaccharide-based formulation provides sufficient energy for growth while avoiding the gut health problems associated with high protein intake, such as ruminitis and ruminal acidosis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively prevents insulin resistance and disrupted glucose homeostasis in calves, improving their metabolic efficiency and overall health while maintaining a high carbohydrate content, thus addressing the limitations of conventional milk replacers.
Implementation Method 1
if lactose present in the feed is converted into its monosaccharides (i.e. glucose and galactose) prior to feeding it to the animals
Data Source
Figure 1~2
AI summary
The present invention relates to a low-lactose dairy-based milk replacer for use in the treatment or prevention of insulin resistance in a bovine subject. The present invention further relates to the use of such a low-lactose dairy-based milk replacer for feeding bovine, in particular calves, such that the development of insulin resistance is prevented.